Core Viewpoint - Medisi plans to enhance its competitive advantage in preclinical integrated research through continuous development and integration strategies [2] Group 1: Business Strategy - The company aims to deepen its integrated research strategy in preclinical studies [2] - Medisi intends to explore suitable opportunities for expanding its upstream and downstream industry chain based on actual business conditions [2] - The company seeks to align its expansion efforts with its internationalization strategy while strengthening its existing research and development technology platform [2] Group 2: Future Plans - Medisi will supplement or enhance its existing business chain as part of its growth strategy [2] - Any future merger and acquisition plans will be executed in accordance with relevant laws and regulations, ensuring timely decision-making and information disclosure [2]